Evidence map›Paper›PMID 30918471›Full record

ArticleMediators of inflammation2019

miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 Years.

Frank Tacke, Martina E Spehlmann, Mihael Vucur, Fabian Benz, Mark Luedde, David Vargas Cardenas, Sanchari Roy, Sven Loosen, Hans-Joerg Hippe, Norbert Frey and 4 more

Abstract read
In one paragraph

Article in Mediators of inflammation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Role of miRNA dysregulation in sepsis.Molecular medicine (Cambridge, Mass.) · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Frank TackeDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.ORCID 0000-0001-6206-0226
Martina E SpehlmannDepartment of Internal Medicine III, University of Kiel, Schittenhelmstrasse 12, 24105 Kiel, Germany.
Mihael VucurDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.ORCID 0000-0003-4078-1668
Fabian BenzDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
Mark LueddeDepartment of Internal Medicine III, University of Kiel, Schittenhelmstrasse 12, 24105 Kiel, Germany.
David Vargas CardenasDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
Sanchari RoyDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
Sven LoosenDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
Hans-Joerg HippeDepartment of Internal Medicine III, University of Kiel, Schittenhelmstrasse 12, 24105 Kiel, Germany.
Norbert FreyDepartment of Internal Medicine III, University of Kiel, Schittenhelmstrasse 12, 24105 Kiel, Germany.
Christian TrautweinDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
Alexander KochDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.
Christoph RoderburgDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.ORCID 0000-0002-2245-6362
Tom LueddeDepartment of Medicine III, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074 Aachen, Germany.ORCID 0000-0002-6288-8821

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlterations in miR-155 serum levels have been described in inflammatory and infectious diseases. Moreover, a role for miR-155 in aging and age-related diseases was recently suggested. We therefore analyzed a potential age-dependent prognostic value of circulating miR-155 as a serum-based marker in critical illness.

methodsConcentrations of circulating miR-155 were determined in 218 critically ill patients and 76 healthy controls.

resultsBy using qPCR, we demonstrate that miR-155 serum levels are elevated in patients with critical illness when compared to controls. Notably, levels of circulating miR-155 were independent on the severity of disease, the disease etiology, or the presence of sepsis. In the total cohort, miR-155 was not an indicator for patient survival. Intriguingly, when patients were subdivided according to their age upon admission to the ICU into those younger than 65 years, lower levels of miR-155 turned out as a strong marker, indicating patient mortality with a similar accuracy than other markers frequently used to evaluate critically ill patients on a medical ICU.

conclusionIn summary, the data provided within this study suggest an age-specific role of miR-155 as a prognostic biomarker in patients younger than 65 years. Our study is the first to describe an age-dependent miRNA-based prognostic biomarker in human diseases.

Indexed as

AdolescentAdultAgedAged, 80 and overBiomarkersCritical IllnessFemaleHumansIntensive Care UnitsMaleMicroRNAsMiddle AgedPrognosisReal-Time Polymerase Chain ReactionYoung AdultBiomarkersMicroRNAsMIRN155 microRNA, human

Identifiers

PMID30918471
PMCPMC6409014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.